Search research articles
Contact Us
Filters
Showing results (91-100 of 159) with videos related to
Page
of 16
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 31, 2023
Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
Maeve A Hennessy, Jeffrey P Leal, Chiung-Yu Huang, et al.
Science Translational Medicine
|
April 22, 2026
Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer
Xiaopeng Sun, Andres A Ocampo, Ann Hanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2016
Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013
Tari A King, Jaclyn P Lyman, Mithat Gonen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer
Nancy U Lin, Véronique Diéras, Devchand Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2015
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
Steven J Isakoff, Erica L Mayer, Lei He, et al.
Breast Cancer Research and Treatment
|
January 3, 2021
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer
Mei-Yin C Polley, Roberto A Leon-Ferre, Samuel Leung, et al.
JCO Precision Oncology
|
July 2, 2025
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma
Maen Abdelrahim, Alejandro Mejia, Abdullah Esmail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2021
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
Roisin M Connolly, Jeffrey P Leal, Lilja Solnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2012
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer
Lisa A Carey, Hope S Rugo, P Kelly Marcom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2015
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer
Andres Forero-Torres, Katherine E Varley, Vandana G Abramson, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 159) with videos related to
Sort By:
Page
of 16
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 31, 2023
Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial)
Maeve A Hennessy, Jeffrey P Leal, Chiung-Yu Huang, et al.
Science Translational Medicine
|
April 22, 2026
Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer
Xiaopeng Sun, Andres A Ocampo, Ann Hanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 23, 2016
Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013
Tari A King, Jaclyn P Lyman, Mithat Gonen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer
Nancy U Lin, Véronique Diéras, Devchand Paul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2015
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
Steven J Isakoff, Erica L Mayer, Lei He, et al.
Breast Cancer Research and Treatment
|
January 3, 2021
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer
Mei-Yin C Polley, Roberto A Leon-Ferre, Samuel Leung, et al.
JCO Precision Oncology
|
July 2, 2025
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma
Maen Abdelrahim, Alejandro Mejia, Abdullah Esmail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2021
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
Roisin M Connolly, Jeffrey P Leal, Lilja Solnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2012
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer
Lisa A Carey, Hope S Rugo, P Kelly Marcom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2015
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer
Andres Forero-Torres, Katherine E Varley, Vandana G Abramson, et al.
Page
of 16